Contraceptive Drugs Market Trends, Size, and Share Report 2024-2028

Written by Karan rawat  »  Updated on: July 07th, 2024

Contraceptive Drugs Market Trends, Size, and Share Report 2024-2028

The global contraceptive drugs market size reached US$ 15.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 20.8 Billion by 2028, exhibiting a growth rate (CAGR) of 5.4% during 2024-2028.

The latest research study “Contraceptive Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2028” The study provides a detailed analysis of the industry, including the global contraceptive drugs market trends, size, share, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

What are Contraceptive drugs?

Contraceptive drugs represent birth control medications that are exclusively prepared to inhibit pregnancy and control the birth rate. They are available in various product categories, such as oral pills, injectables, topical solutions, etc. These contraceptive drugs are synthetically formulated using two female hormones, which include estrogen and progestin, that prevent ovulation, thicken cervical mucus, or alter the womb lining to restrict the entrance of sperm into the cervix for implantation and fertilization. They prove highly effective in lowering the risks of ovarian cancer, bone thinning, infections in the fallopian tubes and uterus, acne, and premenstrual syndrome (PMS). Consequently, contraceptive drugs are administered by healthcare practitioners to avert unwanted pregnancy amongst women of childbearing age.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/contraceptive-drugs-market/requestsample

Contraceptive Drugs Market Trends and Drivers:

The expanding population, the elevating consumer consciousness regarding family planning, and the rising instances of unintended pregnancies are primarily driving the contraceptive drugs market. Furthermore, the shifting preferences among healthcare practitioners toward modern contraceptive procedures over conventional ones, on account of their multiple benefits, including optimal safety and enhanced clinical outcomes, are acting as significant growth-inducing factors. Besides this, the increasing rates of approvals of novel medications by several government bodies are also positively influencing the global market. Moreover, the launch of non-hormonal vaginal gels and gelatin capsules that create an inhospitable environment for sperm to sustain by maintaining vagina pH levels is further catalyzing the market growth. Apart from this, the inflating investments in research and development (R&D) activities and the introduction of numerous initiatives by non-governmental organizations (NGOs) and health agencies to sensitize consumers about women’s health, sexual wellness, and contraception techniques are expected to propel the contraceptive drugs market in the coming years.

Contraceptive Drugs Market Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AbbVie Inc., Afaxys Inc., Agile Therapeutics, Amneal Pharmaceuticals Inc., Bayer AG, Johnson & Johnson, Mithra Pharmaceuticals SA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd. and Viatris Inc.

The report has segmented the market on the basis of product, age group and distribution channel.

Breakup by Product:

Oral Contraceptive Pills

Injectable Contraceptives

Topical Contraceptives

Breakup by Age Group:

15–24 years

25–34 years

35–44 years

Above 44 years

Breakup by Distribution Channel:

Retail Pharmacy

Hospital Pharmacy

Clinics

Online Channel

Public Channel and NGOs

Others

Breakup by Region:

North America: (United States, Canada)

Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

Latin America: (Brazil, Mexico, Others)

Middle East and Africa

Key highlights of the report:

Market Performance

Market Outlook

Porter’s Five Forces Analysis

Market Drivers and Success Factors

SWOT Analysis

Value Chain

Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

1 Preface

2 Scope and Methodology

    2.1 Objectives of the Study

    2.2 Stakeholders

    2.3 Data Sources

        2.3.1 Primary Sources

        2.3.2 Secondary Sources

    2.4 Market Estimation

        2.4.1 Bottom-Up Approach

        2.4.2 Top-Down Approach

    2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

    4.1 Overview

    4.2 Key Industry Trends

5 Global Contraceptive Drugs Market

    5.1 Market Overview

    5.2 Market Performance

    5.3 Impact of COVID-19

    5.4 Market Forecast

6 Market Breakup by Product

    6.1 Oral Contraceptive Pills

        6.1.1 Market Trends

        6.1.2 Market Forecast

    6.2 Injectable Contraceptives

        6.2.1 Market Trends

        6.2.2 Market Forecast

    6.3 Topical Contraceptives

        6.3.1 Market Trends

        6.3.2 Market Forecast

7 Market Breakup by Age Group

    7.1 15–24 years

        7.1.1 Market Trends

        7.1.2 Market Forecast

    7.2 25–34 years

        7.2.1 Market Trends

        7.2.2 Market Forecast

    7.3 35–44 years

        7.3.1 Market Trends

        7.3.2 Market Forecast

    7.4 Above 44 years

        7.4.1 Market Trends

        7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

    8.1 Retail Pharmacy

        8.1.1 Market Trends

        8.1.2 Market Forecast

    8.2 Hospital Pharmacy

        8.2.1 Market Trends

        8.2.2 Market Forecast

    8.3 Clinics

        8.3.1 Market Trends

        8.3.2 Market Forecast

    8.4 Online Channel

        8.4.1 Market Trends

        8.4.2 Market Forecast

    8.5 Public Channel and NGOs

        8.5.1 Market Trends

        8.5.2 Market Forecast

    8.6 Others

        8.6.1 Market Trends

        8.6.2 Market Forecast

9 Market Breakup by Region

    9.1 North America

        9.1.1 United States

           9.1.1.1 Market Trends

           9.1.1.2 Market Forecast

        9.1.2 Canada

           9.1.2.1 Market Trends

           9.1.2.2 Market Forecast

    9.2 Asia-Pacific

        9.2.1 China

           9.2.1.1 Market Trends

           9.2.1.2 Market Forecast

        9.2.2 Japan

           9.2.2.1 Market Trends

           9.2.2.2 Market Forecast

        9.2.3 India

           9.2.3.1 Market Trends

           9.2.3.2 Market Forecast

        9.2.4 South Korea

           9.2.4.1 Market Trends

           9.2.4.2 Market Forecast

        9.2.5 Australia

           9.2.5.1 Market Trends

           9.2.5.2 Market Forecast

        9.2.6 Indonesia

           9.2.6.1 Market Trends

           9.2.6.2 Market Forecast

        9.2.7 Others

           9.2.7.1 Market Trends

           9.2.7.2 Market Forecast

    9.3 Europe

        9.3.1 Germany

           9.3.1.1 Market Trends

           9.3.1.2 Market Forecast

        9.3.2 France

           9.3.2.1 Market Trends

           9.3.2.2 Market Forecast

        9.3.3 United Kingdom

           9.3.3.1 Market Trends

           9.3.3.2 Market Forecast

        9.3.4 Italy

           9.3.4.1 Market Trends

           9.3.4.2 Market Forecast

        9.3.5 Spain

           9.3.5.1 Market Trends

           9.3.5.2 Market Forecast

        9.3.6 Russia

           9.3.6.1 Market Trends

           9.3.6.2 Market Forecast

        9.3.7 Others

           9.3.7.1 Market Trends

           9.3.7.2 Market Forecast

    9.4 Latin America

        9.4.1 Brazil

           9.4.1.1 Market Trends

           9.4.1.2 Market Forecast

        9.4.2 Mexico

           9.4.2.1 Market Trends

           9.4.2.2 Market Forecast

        9.4.3 Others

           9.4.3.1 Market Trends

           9.4.3.2 Market Forecast

    9.5 Middle East and Africa

        9.5.1 Market Trends

        9.5.2 Market Breakup by Country

        9.5.3 Market Forecast

10 SWOT Analysis

    10.1 Overview

    10.2 Strengths

    10.3 Weaknesses

    10.4 Opportunities

    10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

    12.1 Overview

    12.2 Bargaining Power of Buyers

    12.3 Bargaining Power of Suppliers

    12.4 Degree of Competition

    12.5 Threat of New Entrants

    12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

    14.1 Market Structure

    14.2 Key Players

    14.3 Profiles of Key Players

        14.3.1 AbbVie Inc.

           14.3.1.1 Company Overview

           14.3.1.2 Product Portfolio

           14.3.1.3 Financials

           14.3.1.4 SWOT Analysis

        14.3.2 Afaxys Inc.

           14.3.2.1 Company Overview

           14.3.2.2 Product Portfolio

        14.3.3 Agile Therapeutics

           14.3.3.1 Company Overview

           14.3.3.2 Product Portfolio

           14.3.3.3 Financials

        14.3.4 Amneal Pharmaceuticals Inc.

           14.3.4.1 Company Overview

           14.3.4.2 Product Portfolio

           14.3.4.3 Financials

        14.3.5 Bayer AG

           14.3.5.1 Company Overview

           14.3.5.2 Product Portfolio

           14.3.5.3 Financials

           14.3.5.4 SWOT Analysis

        14.3.6 Johnson & Johnson

           14.3.6.1 Company Overview

           14.3.6.2 Product Portfolio

           14.3.6.3 Financials

           14.3.6.4 SWOT Analysis

        14.3.7 Mithra Pharmaceuticals SA

           14.3.7.1 Company Overview

           14.3.7.2 Product Portfolio

           14.3.7.3 Financials

        14.3.8 Novartis AG

           14.3.8.1 Company Overview

           14.3.8.2 Product Portfolio

           14.3.8.3 Financials

           14.3.8.4 SWOT Analysis

        14.3.9 Pfizer Inc.

           14.3.9.1 Company Overview

           14.3.9.2 Product Portfolio

           14.3.9.3 Financials

           14.3.9.4 SWOT Analysis

        14.3.10 Teva Pharmaceutical Industries Ltd.

           14.3.10.1 Company Overview

           14.3.10.2 Product Portfolio

           14.3.10.3 Financials

           14.3.10.4 SWOT Analysis

        14.3.11 Viatris Inc.

           14.3.11.1 Company Overview

           14.3.11.2 Product Portfolio

           14.3.11.3 Financials

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Related Posts